Surgical Science Sweden

Delayed Procurement And OEM Reliance Will Test Margins But Improve

AnalystLowTarget

Not Invested

Consensus Narrative from 5 Analysts

Published

31 Aug 25

Updated

31 Aug 25

AnalystLowTarget's Fair Value

SEK 120.00

21.7% undervalued

31 Aug

SEK 93.90

-17.4%

-6.1%

-17.4%

-6.1%

Edit anytime before Aug 31 10:18 PM. Then post Updates to your followers.

Author's Valuation

SEK 120.0

21.7% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

SEK 120.0

21.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.94%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.54%

Calculation

SEK 332.65m

Earnings '28

21.63x

PE Ratio '28

SEK 7.20b

Market Cap '28

SEK 7.20b

Market Cap '28

51.03m

No. shares '28

SEK 141.02

Share Price '28

SEK 141.02 Share Price '28

Discounted to 2025 @ 5.55% p.a.

SEK 119.94

Fair Value '25